Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

A Phase 1/2 Study of VS-6766 in Combination with Sotorasib in Patients with KRAS G12C mutant Non-Small Cell Lung Cancer (NSCLC) (RAMP 203) (VS-6766-203)

  • Details

ClinicalTrials.gov ID: NCT05074810
Diagnosis Type: Lung Cancer
USOR Number: 21498

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 754-1256

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 2 open-label study of loncastuximab tesirine in combination with rituximab (Lonca-R) in previously untreated unfit/frail patients with diffuse large B-cell lymphoma (DLBCL) (LOTIS-9/ ADCT-402-203)

  • Details

ClinicalTrials.gov ID: NCT05144009
Diagnosis Type: Lymphomas
USOR Number: 21469

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1, First-In-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second LIne and CUE-101 Combination Therapy with Pembrolizumab in First Line Patients with HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) (CUE-101-01)

  • Details

ClinicalTrials.gov ID: NCT03978689
Diagnosis Type: Head and Neck Cancer
USOR Number: 21459

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

A Phase 1, First-In-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second LIne and CUE-101 Combination Therapy with Pembrolizumab in First Line Patients with HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) (CUE-101-01)

  • Details

ClinicalTrials.gov ID: NCT03978689
Diagnosis Type: Head and Neck Cancer
USOR Number: 21459

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 754-1256

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression (IMGN853-0419)

  • Details

ClinicalTrials.gov ID: NCT05041257
Diagnosis Type: Peritoneal Cancer
USOR Number: 21369

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

AN OPEN-LABEL, MULTICENTER, PHASE II TRIAL EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF SUBCUTANEOUS MOSUNETUZUMAB MONOTHERAPY IN PATIENTS WITH SELECT B-CELL MALIGNANCIES (ML43389)

  • Details

ClinicalTrials.gov ID: NCT05207670
Diagnosis Type: Lymphomas
USOR Number: 21356

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A PHASE I-III, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE THERAPIES IN COHORTS OF PATIENTS SELECTED ACCORDING TO BIOMARKER STATUS, WITH LOCALLY ADVANCED, UNRESECTABLE, STAGE III NON-SMALL CELL LUNG CANCER (BO42777)

  • Details

ClinicalTrials.gov ID: NCT05170204
Diagnosis Type: Lung Cancer
USOR Number: 21318

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

A PHASE I-III, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE THERAPIES IN COHORTS OF PATIENTS SELECTED ACCORDING TO BIOMARKER STATUS, WITH LOCALLY ADVANCED, UNRESECTABLE, STAGE III NON-SMALL CELL LUNG CANCER (BO42777)

  • Details

ClinicalTrials.gov ID: NCT05170204
Diagnosis Type: Lung Cancer
USOR Number: 21318

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 754-1256

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

UPIFITAMAB RILSODOTIN (XMT-1536)AN OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND EXPANSION STUDY OF UPIFITAMAB RILSODOTIN IN COMBINATION WITH CARBOPLATIN IN PARTICIPANTS WITH HIGH-GRADE SEROUS OVARIAN CANCER: A MODULAR STUDY RELATED TO UPGRADE UMBRELLA MASTER STUDY (UPGRADE-A) (MER-XMT-1536-2A)

  • Details

ClinicalTrials.gov ID: NCT04907968
Diagnosis Type: Peritoneal Cancer
USOR Number: 21309

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1/2 Dose-Escalation and Dose-Expansion Study of ZN‑c3 in Combination with Niraparib in Subjects with Platinum-Resistant Ovarian Cancer (ZN-c3-006)

  • Details

ClinicalTrials.gov ID: NCT05198804
Diagnosis Type: Ovarian Cancer
USOR Number: 21308

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page